Your Statin, Your Brain, and a Governor Who Actually Showed Up
Quick Summary
This episode covers three developments at the intersection of menopause and brain health, cardiovascular risk, and workplace policy. A new NAMS journal study finds statins may be adding to the cognitive and symptom burden postmenopausal women already carry — and that the overlap is almost certainly being misread. A separate study shows that APOE4 carriers may not get the same brain-protective benefits from estrogen that other women do, which matters enormously for how we think about HRT and Alzheimer's risk. And Washington State's governor just signed an Executive Order making menopause support in the workplace official policy.
Your Statin, Your Brain, and a Governor Who Actually Showed Up
Key Takeaways
- ✦A study in the NAMS journal found statin use in postmenopausal women was linked to poorer delayed recall memory, worse visuospatial function, higher menopause symptom burden, and elevated sarcopenia risk — effects that can easily be misattributed to menopause alone.
- ✦Statins were not associated with mild cognitive impairment in this study, which is an important distinction — but the subtler cognitive and physical effects are still clinically meaningful and worth flagging with your doctor.
- ✦A 2026 study found that the APOE4 genotype negates the protective effects of ovarian hormones on cerebrovascular endothelial and mitochondrial function — meaning estrogen's brain benefits may not apply equally to women who carry this Alzheimer's risk gene.
- ✦Washington Governor Bob Ferguson signed an Executive Order directing state agencies to support employees experiencing perimenopause and menopause in the workplace — one of the more concrete government actions on this issue in the US to date.
- ✦Both brain-health studies point toward the need for more individualized care: knowing your APOE4 status and your medication profile matters more than most standard menopause appointments currently account for.
Sources & References
- 🔬Statin use linked to poorer memory, visuospatial function, and higher menopause symptom burden in postmenopausal women
- 🔬APOE4 genotype negates the protective effects of ovarian hormones on cerebrovascular and mitochondrial function
- 📰Governor Ferguson signs Executive Order supporting women experiencing perimenopause and menopause in the workplace
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.